Company Analysis
Sign in

IGC Pharma, Inc. (IGC)

NYSE: IGC · Pharmaceutical Preparations · Potomac, MD · filing with the SEC since 2005
Full chart Alerts Compare
Grade5.0
◀ Past 4.0● Present 6.2▶ Future 4.7
3 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Income statement, as filed

In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period endingMar 31, 2025Mar 31, 2024Mar 31, 2023Mar 31, 2022Mar 31, 2021Mar 31, 2020Mar 31, 2019Mar 31, 2018Mar 31, 2017Mar 31, 2016
Report filedJun 27, 2025Jun 24, 2024Jul 7, 2023Jun 23, 2022Jun 14, 2021Jul 13, 2020Jun 14, 2019Jun 21, 2018Jul 14, 2017·
Revenue1,271,0001,345,000911,000397,000898,0004,072,0005,116,0002,193,000r580,3726,366,550
Cost of revenue652,000612,000469,000203,000785,0003,957,0004,984,0002,111,000r362,1355,523,256
Gross profit619,000733,000442,000194,000113,000115,000132,00082,000r218,237·
Research and development3,655,0003,773,0003,461,0002,330,000929,0001,011,0001,256,000137,000··
Selling, general and administrative4,410,0006,758,0008,552,00013,292,0007,908,0005,968,0003,519,0001,734,000r2,271,690r2,702,753
Operating income-7,446,000-9,798,000-11,571,000-15,428,000-8,724,000-6,864,000-4,643,000-1,789,000r-2,054,385-2,905,710
Interest expense5,0005,0005,0005,0003,000··30,74293,648213,928
Interest and investment income········1,7442,085
Share of profit of equity-method investments·······0317,7420
Other income (expense), net325,000143,00065,000461,00082,000331,000548,0003,000r215,955r284,186
Income before income taxes-7,121,000-13,000,000-11,506,000-15,016,000-8,811,000-7,315,000-4,095,000-1,786,000r-1,838,430-2,833,367
Income tax expense0000002,0000r14,431579
Net income including non-controlling interests-7,121,000-13,000,000-11,506,000-15,016,000-8,811,000-7,315,000-4,097,000-1,786,000r-1,852,861-2,833,946
Net income to non-controlling interests·······9,000r14,399-25,702
Net income-7,122,000-13,000,000-11,506,000-15,016,000-8,811,000-7,315,000-4,097,000-1,786,000r-1,867,260-2,808,244
Earnings per share, basic-0.09-0.22······-0.07-0.17
Earnings per share, diluted-0.09-0.22······-0.07-0.17
Earnings per share, basic and diluted····-0.21-0.19-0.13-0.06-0.07·
Weighted average shares, basic76,517,17558,839,86852,576,25849,991,63141,963,38239,490,01435,393,40727,937,28725,658,54416,387,290
Weighted average shares, diluted76,517,17558,839,868······25,658,54416,387,290
Weighted average shares, basic and diluted····41,963,38239,490,014r35,39327,937r25,658,544·
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-10 reverse split.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldus-gaap:Revenues
Cost of revenue what it cost to make or buy what it soldus-gaap:CostOfRevenue
Gross profit revenue less the cost of what it soldus-gaap:GrossProfit
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative the cost of selling and of running the companyus-gaap:SellingGeneralAndAdministrativeExpense
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest expense what its borrowing costus-gaap:InterestExpenseDebt
us-gaap:InterestExpense
Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeInterest
Share of profit of equity-method investments its share of companies it partly ownsus-gaap:IncomeLossFromEquityMethodInvestments
Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss
Net income to non-controlling interests the share that belongs to minority holdersus-gaap:NetIncomeLossAttributableToNoncontrollingInterest
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
SI Assistanton IGC · research, not advice